<?xml version='1.0' encoding='utf-8'?>
<document id="18624679"><sentence text="Potential role of intestinal first-pass metabolism in the prediction of drug-drug interactions." /><sentence text="The contribution of intestine to the magnitude of drug-drug interactions (DDI) may be significant, considering high levels of inhibitors in the gut lumen achieved during absorption and the abundance of metabolic enzymes in the mature enterocytes" /><sentence text=" Intestinal inhibition is incorporated in the DDI prediction models as the ratio of the intestinal wall availability in the presence and absence of the inhibitor (F(G)(') and F(G), respectively)" /><sentence text="" /><sentence text="This review will focus on the ability of the current approaches to estimate the extent of intestinal DDI accurately, addressing predominantly the most abundant intestinal P450 enzyme, CYP3A4" /><sentence text="" /><sentence text="Considering the sensitivity of the DDI prediction models to the accuracy of the F(G) estimates, the current study focuses on 3 different in vitro and in vivo approaches to assess this parameter"><entity charOffset="80-94" id="DDI-PubMed.18624679.s7.e0" text="F(G) estimates" /></sentence><sentence text="" /><sentence text="The advantages and limitations of each of F(G) methods are outlined" /><sentence text=" Accurate assessment of this parameter is essential for the prediction of human drug clearance and drug-drug interaction potential" /><sentence text="" /></document>